Search

Your search keyword '"Yi, Shounan"' showing total 2 results
Start Over Author "Yi, Shounan" Region china
2 results on '"Yi, Shounan"'

1. Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12–14, 2018: "The 2018 Changsha Communiqué" The 10‐Year Anniversary of The International Consultation on Xenotransplantation

Author

Hawthorne, Wayne J., Cowan, Peter J., Bühler, Léo H., Yi, Shounan, Bottino, Rita, Pierson, Richard N., Ahn, Curie, Azimzadeh, Agnes, Cozzi, Emanuele, Gianello, Pierre, Lakey, Jonathan R. T., Luo, Minhua, Miyagawa, Shuji, Mohiuddin, Muhammad M., Park, Chung‐Gyu, Schuurman, Henk‐Jan, Scobie, Linda, Sykes, Megan, Tector, Joseph, and Tönjes, Ralf Reinhard

Subjects
XENOTRANSPLANTATION, BK virus, CIRCOVIRUS diseases, CLINICAL trials, HEALTH services administration, PHYSICIANS, CORNEAL transplantation
Abstract

The article discusses the third World Health Organization (WHO) Global conference on regulatory requirements for Xenotransplantation clinical trials that was held in Changsha, China on 12–14 December, 2018. It mentions recent advances in the development of technologies for solid organ xenotransplantation; and also mentions Dr. Megan Sykes reviewed the current technologies and studies in the development of tolerance and use of regulatory T cells.

Published
2019
Full Text
View/download PDF

2. Regulatory T-Cell Levels in the Longest Surviving Asian Patient After Heart-Lung Transplant.

Author

Huang L, Ji M, Yi S, and Zhou X

Subjects
Adult, CD4 Lymphocyte Count, China, Eisenmenger Complex diagnosis, Graft Rejection immunology, Graft Rejection prevention & control, Humans, Immunosuppressive Agents therapeutic use, Male, Time Factors, Treatment Outcome, Eisenmenger Complex surgery, Graft Survival drug effects, Heart-Lung Transplantation, Survivors, T-Lymphocytes, Regulatory immunology
Abstract

Heart-lung transplant is the most effective therapy for patients with end-stage cardiopulmonary disease. Here, we report an initial assessment of a 31-year-old man who had survived more than 11 years after heart-lung transplant, which represents the longest survival time in this procedure in Asian studies. At his 11th anniversary after transplant, extensive tests were carried out, especially to detect regulatory T-cell levels for the first time in a surviving heart-lung transplant recipient. Preliminarily data revealed the status of his immunologic function in relation to chronic allograft rejection. All data indicated that the patient was in good condition. This is the first study detecting regulatory T-cell levels in a heart-lung transplant patient.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results